Reposted by haysamrady
6/ Incremental dialysis may “preserve RRF,” but current evidence is observational, biased, and non‑adjudicated. Healthier patients are selected, not randomized. CV benefit is unproven. Only high‑RRF incident patients with strict monitoring fit the strategy
October 3, 2026 at 9:23 PM
6/ Incremental dialysis may “preserve RRF,” but current evidence is observational, biased, and non‑adjudicated. Healthier patients are selected, not randomized. CV benefit is unproven. Only high‑RRF incident patients with strict monitoring fit the strategy
Reposted by haysamrady
🔹 @kireports.bsky.social - identifying serum alkaline phosphatase as a potential biomarker for AVF maturation failure.
🔹 Kidney International Case Reports™ - a case highlighting the role of genetic diagnosis and lumasiran in recurrent oxalate nephropathy after kidney transplantation.
🔹 Kidney International Case Reports™ - a case highlighting the role of genetic diagnosis and lumasiran in recurrent oxalate nephropathy after kidney transplantation.
October 1, 2026 at 10:00 AM
🔹 @kireports.bsky.social - identifying serum alkaline phosphatase as a potential biomarker for AVF maturation failure.
🔹 Kidney International Case Reports™ - a case highlighting the role of genetic diagnosis and lumasiran in recurrent oxalate nephropathy after kidney transplantation.
🔹 Kidney International Case Reports™ - a case highlighting the role of genetic diagnosis and lumasiran in recurrent oxalate nephropathy after kidney transplantation.